TOWARD CYSTIC FIBROSIS GENE THERAPY
- 1 February 1997
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 48 (1) , 203-216
- https://doi.org/10.1146/annurev.med.48.1.203
Abstract
▪ Abstract Cystic fibrosis (CF) is a common genetic disorder characterized by defective epithelial chloride transport and progressive lung disease. Although great strides have been made in the treatment of CF, it remains lethal, often by early adulthood. CF is one of the most extensively researched genetic diseases as a target for gene therapy development. It may also serve as an important model for gene therapy of other diseases. Preclinical and clinical research has lead to the rapid development of a variety of vectors designed to correct the basic defect in CF, including adenovirus, adeno-associated virus, and liposomes. Clinical studies have identified the host immune response and low vector efficiency as key impediments to effective CF gene therapy. Further research promises to refine vector technology and bring CF gene therapy to the bedside.Keywords
This publication has 74 references indexed in Scilit:
- Molecular Strategies for Therapy of Cystic FibrosisAnnual Review of Pharmacology and Toxicology, 1995
- Gene therapy approaches for cystic fibrosisBiologicals, 1995
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Gene Therapy for Cystic Fibrosis Utilizing a Replication Deficient Recombinant Adenovirus Vector to Deliver the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Airways. A Phase I Study. Children's Hospital Medical Center, Cincinnati, OhioHuman Gene Therapy, 1994
- Gene Therapy of Cystic Fibrosis Lung Disease Using E1 Deleted Adenoviruses: A Phase I Trial. University of Michigan, Ann Arbor, Michigan and University of Pennsylvania, Philadelphia, PennsylvaniaHuman Gene Therapy, 1994
- Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growthEuropean Respiratory Journal, 1994
- Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channelsNature Genetics, 1993
- Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic FibrosisHuman Gene Therapy, 1993
- Reconstitution of tracheal grafts with a genetically modified epithelium.Proceedings of the National Academy of Sciences, 1991
- Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.Journal of Clinical Investigation, 1989